期刊文献+

BMP2真核表达载体的构建 被引量:1

Construction of BMP2 gene mammal expression plasmid
下载PDF
导出
摘要 目的为研究骨缺损的基因治疗提供实验基础,构建人骨形态发生蛋白2真核表达载体。方法采用双酶切方法克隆载体将骨形态发生蛋白2基因与真核表达载体pcDNA3.1连接,构建pcDNA3.1-BMP2表达基因载体。结果通过测序分析证实,成功构建BMP2真核表达载体。结论成功构建BMP2表达载体。 Objective To clone and construct mammal expression vector for human bone morphogenetic protein 2 (BMP2),in order to study gene .therapy for bone defect disease.Methods Plasmid pSPBMP2 was digested by Xba Ⅰ and Sal Ⅰ , the BMP2 gene was subcloned into pcDNA3.1. Results The mammal expression plasmid for BMP2, pcDNA3.1-BMP2, had been constructed. The cloned DNA BMP2 gene was confirmed by sequencing. Conclusion The mammal expression plasmid for BMP2 had been successfully constructed.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2007年第6期524-526,共3页 Journal of Harbin Medical University
基金 黑龙江科技攻关项目(GB01C123-01)
关键词 骨形态发生蛋白-2 基因 基因载体 bone morphogenetic protein 2 gene genetic vector
  • 相关文献

参考文献7

  • 1Gamradt SC,Abe N, Bahamonde ME,et al. Tracking expression of vitally mediated BMP-2 in gene therapy for bone repair[J]. Clin Orthop Relat Res, 2006,450: 238-245.
  • 2Wozney JM, Rosen V, Celeste A J, et al. Novel regulators of bone formation: molecular clones and activities[ J ]. Science, 1988,242 (4885) : 1528-1534.
  • 3Yang M, Ma QJ, Dang GT, et el. In vitro and in vivo induction of bone formation based on ex vivo gene therapy using rat edipose-derived adult stem cells expressing BMP-7[J] .Cytotherapy,2005,7(3) :273-281.
  • 4Yue B, Lu B, Dai KR, et al. BMP2 gene therapy on the repair of bone defects of aged rats[ J ]. Calcif Tissue Int, 2005,77 (6) : 395-403.
  • 5Musgrave DS,Pruchnic R,Bosch P, et el. Human skeletal muscle cells in ex vivo gene therapy to dehver bone morphogenetic protein-2[ J]. J Bone Joint Suig Br,2002,84( 1 ) : 120-127.
  • 6Bright C, Park YS, Sieber AN, et al. In vivo evaluation of plasmid DNA encoding OP- 1 protein for spine fusion [ J ]. Spine, 2006,31 (19) : 2163- 2172.
  • 7Endo M, Kureda S, Kondo H, et al. Bone regeneration by modified gone-activated matrix: effectiveness in segmental tibial defects in rats [J]. Tissue Eng,2006,12(3) :489-497.

同被引文献14

  • 1宗莉,陈伶俐,张淑芸,杨晓容,朱家壁.壳聚糖纳米粒作为基因载体的研究:制备,特征和对DNA的保护[J].中国药科大学学报,2005,36(6):526-530. 被引量:16
  • 2Bragdon B, Moseychuk O, Saldanha S, et al. Bone morpho-genetic proteins: a critical review [J]. Cell Signal, 2011,23(4):609-620.
  • 3Toh EK, Chen HY, Lo YL, et al. Succinated chitosan as agene carrier for improved chitosan solubility and gene trans-fection[J]. Nanomedicine, 2011, 7(2):174-183.
  • 4Saranya N, Moorthi A,Saravanan S, et al. Chitosan and itsderivatives for gene delivery [J]. Int J Biol Macromol, 2011,48(2):234-238.
  • 5Ross PC, Hui SW. Lipoplex size is a major determinant ofin vitro lipofection efEiciency[J]. Gene Ther, 1999, 6(4):651-659.
  • 6Grenha A. Chitosan nanoparticles: a survey of preparationmethods[J]. J Drug Target, 2012,20(4):291-300.
  • 7Ishii T, Okahata Y, Sato T. Mechanism of cell transfectionwith plasmid/chitosan complexes[J]. Biochim Biophys Acta,2001’ 1514(1):51-64.
  • 8Lee M, Nah JW, Kwon Y, et al. Water-soluble and low mo-lecular weight chitosan-based plasmid DNA delivery [J].Pharm Res, 2001,18(4):427-431.
  • 9Erbacher P, Zou S,Bettinger T,et al. Chitosan-based vector/DNA complexes for gene delivery: biophysical characte-ristics and transfection ability [J]. Pharm Res, 1998,15(9):1332-1339.
  • 10Huang M,Fong CW, Khor E, et al. Transfection efficiencyof chitosan vectors: effect of polymer molecular weight anddegree of deacetylation[J]. J Control Release, 2005,106(3):391-406.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部